341 related articles for article (PubMed ID: 20843732)
1. Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy.
Ihloff AS; Petersen C; Hoffmann M; Knecht R; Tribius S
Oral Oncol; 2010 Oct; 46(10):705-11. PubMed ID: 20843732
[TBL] [Abstract][Full Text] [Related]
2. Oropharyngeal cancer - is it time to change management according to human papilloma virus status?
Mehanna H; Olaleye O; Licitra L
Curr Opin Otolaryngol Head Neck Surg; 2012 Apr; 20(2):120-4. PubMed ID: 22327790
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
[TBL] [Abstract][Full Text] [Related]
4. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy.
Huang SH; Perez-Ordonez B; Liu FF; Waldron J; Ringash J; Irish J; Cummings B; Siu LL; Kim J; Weinreb I; Hope A; Gullane P; Brown D; Shi W; O'Sullivan B
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):276-83. PubMed ID: 20950953
[TBL] [Abstract][Full Text] [Related]
5. HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior.
Kraft S; Faquin WC; Krane JF
Am J Surg Pathol; 2012 Mar; 36(3):321-30. PubMed ID: 22301491
[TBL] [Abstract][Full Text] [Related]
6. What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?
Urban D; Corry J; Rischin D
Cancer; 2014 May; 120(10):1462-70. PubMed ID: 24578320
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
Ang KK; Sturgis EM
Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
[TBL] [Abstract][Full Text] [Related]
8. Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer.
Dahlstrom KR; Li G; Hussey CS; Vo JT; Wei Q; Zhao C; Sturgis EM
Cancer; 2015 Oct; 121(19):3455-64. PubMed ID: 26094818
[TBL] [Abstract][Full Text] [Related]
9. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
Weinberger PM; Yu Z; Haffty BG; Kowalski D; Harigopal M; Brandsma J; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
J Clin Oncol; 2006 Feb; 24(5):736-47. PubMed ID: 16401683
[TBL] [Abstract][Full Text] [Related]
10. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
Licitra L; Perrone F; Bossi P; Suardi S; Mariani L; Artusi R; Oggionni M; Rossini C; Cantù G; Squadrelli M; Quattrone P; Locati LD; Bergamini C; Olmi P; Pierotti MA; Pilotti S
J Clin Oncol; 2006 Dec; 24(36):5630-6. PubMed ID: 17179101
[TBL] [Abstract][Full Text] [Related]
11. Impact of HPV status on treatment of squamous cell cancer of the oropharynx: what we know and what we need to know.
Tribius S; Ihloff AS; Rieckmann T; Petersen C; Hoffmann M
Cancer Lett; 2011 May; 304(2):71-9. PubMed ID: 21376458
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck.
Ringström E; Peters E; Hasegawa M; Posner M; Liu M; Kelsey KT
Clin Cancer Res; 2002 Oct; 8(10):3187-92. PubMed ID: 12374687
[TBL] [Abstract][Full Text] [Related]
13. Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpression is associated with positive high-risk HPV status and improved survival.
Cai C; Chernock RD; Pittman ME; El-Mofty SK; Thorstad WL; Lewis JS
Am J Surg Pathol; 2014 Jun; 38(6):809-15. PubMed ID: 24698966
[TBL] [Abstract][Full Text] [Related]
14. Head and neck squamous cell carcinoma: role of the human papillomavirus in tumour progression.
De Petrini M; Rittà M; Schena M; Chiusa L; Campisi P; Giordano C; Landolfo V; Pecorari G; Landolfo S
New Microbiol; 2006 Jan; 29(1):25-33. PubMed ID: 16608122
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Haughey BH; Sinha P
Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
[TBL] [Abstract][Full Text] [Related]
16. [High-risk human papilloma virus associated oropharynx squamous cell carcinomas: clinical, biological implications and therapeutical perspectives].
Guihard S; Jung AC; Noël G
Cancer Radiother; 2012 Feb; 16(1):34-43. PubMed ID: 22316562
[TBL] [Abstract][Full Text] [Related]
17. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
Nichols AC; Finkelstein DM; Faquin WC; Westra WH; Mroz EA; Kneuertz P; Begum S; Michaud WA; Busse PM; Clark JR; Rocco JW
Clin Cancer Res; 2010 Apr; 16(7):2138-46. PubMed ID: 20233885
[TBL] [Abstract][Full Text] [Related]
18. The changing aetiology of head and neck cancer: the role of human papillomavirus.
Evans M; Powell NG
Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):538-46. PubMed ID: 20584591
[TBL] [Abstract][Full Text] [Related]
19. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.
Sano D; Oridate N
Int J Clin Oncol; 2016 Oct; 21(5):819-826. PubMed ID: 27339270
[TBL] [Abstract][Full Text] [Related]
20. Use of combined molecular biomarkers for prediction of clinical outcomes in locally advanced tonsillar cancers treated with chemoradiotherapy alone.
Chung YL; Lee MY; Horng CF; Jian JJ; Cheng SH; Tsai SY; Hsieh CI; Yen LK; Lin CY
Head Neck; 2009 Jan; 31(1):9-20. PubMed ID: 18767174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
